| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Apr 08, 2024 | Apr 11, 2024 | Wills Robert James Dir | Buy | $8.96 | $27,655 | +23.58% |
| Mar 28, 2024 | Apr 01, 2024 | Wills Robert James Dir | Buy | $8.48 | $58,602 | +50.00% |
| Feb 23, 2024 | Feb 27, 2024 | Hale David F Dir | Buy | $9.04 | $8,859 | +3.04% |
| Feb 23, 2024 | Feb 27, 2024 | Wills Robert James Dir | Sell | $9.04 | $8,859 | -0 |
| Jun 12, 2023 | Jun 14, 2023 | Kaufmann Gunnar F. Chief Scientific Officer | Buy | $0.35 | $9,824 | +22.82% |
| Apr 13, 2023 | Apr 17, 2023 | Breitmeyer James B CEO | Buy | $0.29 | $43,930 | +16.43% |
| Apr 12, 2023 | Apr 14, 2023 | Yazji Salim Chief Medical Officer | Buy | $0.29 | $7,200 | +13.18% |
| Apr 12, 2023 | Apr 14, 2023 | Leavitt Chase C. GC Secretary | Buy | $0.29 | $7,250 | +18.95% |
| Apr 13, 2023 | Apr 14, 2023 | Vincent Richard G CFO | Buy | $0.3 | $8,961 | +15.53% |
| Mar 24, 2022 | Mar 28, 2022 | Vincent Richard G CFO | Buy | $1.44 | $7,210 | +5.02% |
| Jan 27, 2022 | Jan 31, 2022 | Vincent Richard G CFO | Buy | $1.73 | $21,625 | +12.25% |
| Jan 27, 2022 | Jan 31, 2022 | Leavitt Chase C. GC Secretary | Buy | $1.72 | $23,280 | +23.13% |
| Jan 27, 2022 | Jan 31, 2022 | Yazji Salim Chief Medical Officer | Buy | $1.69 | $16,900 | +12.96% |
| Jan 27, 2022 | Jan 31, 2022 | Breitmeyer James B CEO | Buy | $1.68 | $42,080 | +5.40% |
| Jun 30, 2021 | Jul 02, 2021 | Hale David F Dir | Sell | $4.75 | $17,428 | -0.50% |
| Jun 11, 2021 | Jun 15, 2021 | Leavitt Chase C. GC Secretary | Buy | $5.45 | $8,175 | +50.00% |
| Sep 01, 2020 | Sep 02, 2020 | Carter Michael G Dir | Buy | $2.1 | $150,001 | +49.82% |
| Jul 21, 2020 | Jul 23, 2020 | Kisner Daniel L Dir | Buy | $2.38 | $23,825 | +50.00% |
| Jul 21, 2020 | Jul 23, 2020 | Aker Hazel M Legal Counsel | Buy | $2.38 | $99,998 | +45.01% |
| Jul 21, 2020 | Jul 23, 2020 | Shanghai Pharmaceutical (Usa) Inc. 10% | Buy | $2.38 | $2M | +22.84% |
| May 21, 2020 | May 22, 2020 | Hale David F Dir | Buy | ~ | $0 | +2.31% |